Source comparison
Adamax vs Semax Amidate: Research Parameter Comparison
Primary Mechanism D2 receptor sensitivity modulation in VTA and nucleus accumbens BDNF upregulation and hippocampal neurogenesis Distinct pathways. Not comparable Onset of Observable Effects 48–72 hours (acute motivational changes) 7–14 days (cumulative neurop
This comparison does not assign a generated winner or score.
- Primary Mechanism
- D2 receptor sensitivity modulation in VTA and nucleus accumbens
- BDNF upregulation and hippocampal neurogenesis
- Distinct pathways. Not comparable
- Onset of Observable Effects
- 48–72 hours (acute motivational changes)
- 7–14 days (cumulative neuroplasticity)
- Adamax for acute studies, Semax for chronic protocols
- Typical Research Dose Range
- 0.5–2 mg subcutaneous daily or every other day
- 300–600 mcg intranasal or subcutaneous daily for 14+ days
- Dosing frequency differs due to mechanism
- Reconstituted Stability
- 28 days at 2–8°C (peptide bond stable)
- 28 days at 2–8°C (protease-sensitive. Intranasal preferred)
- Both require cold storage; Semax more enzymatically fragile
- Primary Research Applications
- Motivation deficit models, reward processing, dopamine circuitry
- Memory consolidation, spatial learning, neuroprotection, cognitive aging
- Select based on behavioral vs cognitive focus
- Tolerance Development
- Minimal. Receptor upregulation persists 72–96 hours
- Not applicable. Neuroplastic effects cumulative, not tolerance-prone
- Neither requires dose escalation in standard protocols